CYCN
Cyclerion Therapeutics, Inc.
6.38
2 x 5.07
2 x 7.24
bid
ask
+
4.83
311.61%
2 @ 04:00 PM
7.39 +1.01 (15.83%)
Ytd 402.36%
1y 151.18%
5.39
day range
8.48
1.03
52 week range
8.48
Open 5.43 Prev Close 1.55 Low 5.39 High 8.48 Mkt Cap 24.28M
Vol 252.32M Avg Vol 1.51M EPS -0.70 P/E N/A Forward P/E -2.44
Beta 1.92 Short Ratio 0.78 Inst. Own 40.41% Dividend N/A Div Yield N/A
Ex Div Date N/A Earning 08-11 50-d Avg 1.39 200-d Avg 2.04 1yr Est 4.00
Earning
Date For Estimate Reported Surprise surprise %
2024-11-14 2024-09 0 -0.29 N/A N/A
2024-08-07 2024-06 0 -0.53 N/A N/A
2024-05-07 2024-03 0 -0.62 N/A N/A
2024-03-27 2023-12 0 N/A N/A N/A
2023-11-13 2023-09 0 -0.93 N/A N/A
2023-07-28 2023-06 0 -1.83 N/A N/A
Upgrade / Downgrade
Date Firm Action From To
Profile
Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.
Insider Holder
Date Name Relation Quantity Description
2023-11-29 DESOUZA ERROL B Director 30.00K Stock Award(Grant)
2023-12-28 GRAUL REGINA MARGARET President 100.30K Stock Award(Grant)
2023-12-28 HECHT PETER M Director and Beneficial Owner of more than 10% of a Class of Security 377.46K Stock Award(Grant)
2023-11-29 HYMAN STEVEN Director 20.00K Stock Award(Grant)
2023-11-29 MCGUIRE TERRANCE G Director 42.01K Stock Award(Grant)
2024-11-20 SLATE PATH CAPITAL LP Beneficial Owner of more than 10% of a Class of Security 0.00 Sale
Institution Ownership
Report Date Organization Position Value Percentage
2024-09-29 Slate Path Capital, LP 357.88K 1.15M 13.21%
2024-09-29 MFN Partners Management, LP 169.46K 542.27K 6.25%
2024-09-29 Tyndall Capital Partners LP 164.78K 527.29K 6.08%
2024-09-29 FMR, LLC 157.64K 504.44K 5.82%
2024-09-29 Siren, L.L.C. 116.16K 371.70K 4.29%
2024-09-29 Geode Capital Management, LLC 33.91K 108.51K 1.25%
Fund Ownership
Report Date Organization Position Value Percentage
2024-09-29 Vanguard Extended Market Index Fund 23.49K 75.17K 0.87%
2024-10-30 Fidelity Growth Company Fund 20.56K 65.80K 0.76%
2024-10-30 Fidelity NASDAQ Composite Index ETF 14.08K 45.05K 0.52%
2024-10-30 Fidelity Extended Market Index Fund 10.83K 34.64K 0.40%
2024-10-30 Fidelity Growth Company K6 Fund 9.22K 29.50K 0.34%
2024-10-30 Fidelity Series Total Market Index Fund 2.33K 7.44K 0.09%
Split
Split Date
1 : 20 2023-05-16